Compare LENZ & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | GEVO |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 568.2M |
| IPO Year | 2021 | 2010 |
| Metric | LENZ | GEVO |
|---|---|---|
| Price | $8.29 | $2.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $45.60 | $6.42 |
| AVG Volume (30 Days) | 1.0M | ★ 4.1M |
| Earning Date | 03-24-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | $711,000.00 |
| Revenue This Year | $162.79 | $19.44 |
| Revenue Next Year | $170.32 | $5.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.40 | $0.92 |
| 52 Week High | $50.19 | $2.95 |
| Indicator | LENZ | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 74.68 |
| Support Level | N/A | $2.25 |
| Resistance Level | $12.70 | $2.95 |
| Average True Range (ATR) | 0.83 | 0.15 |
| MACD | -0.23 | 0.03 |
| Stochastic Oscillator | 0.45 | 80.47 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.